SCHEMBL8098491

SCHEMBL8098491

Cc1ccc(Nc2ccccc2)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.59
MAPK13 O15264 1/20 0.58
MAPK12 P53778 1/20 0.58
MAPK11 Q15759 1/20 0.58
MAPK14 Q16539 1/20 0.58
HPGD P15428 3/20 0.54
NPSR1 Q6W5P4 2/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
PKM P14618 1/20 0.52
ALDH1A1 P00352 7/20 0.52
MAPK1 P28482 3/20 0.52
HSD17B10 Q99714 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9513146 0.92 RAPGEF4 (0.68) RAPGEF4MAPK13MAPK12MAPK11MAPK14
SCHEMBL15145097 0.82 ALDH1A1 (0.58) RAPGEF4MAPK13MAPK12MAPK11MAPK14
SCHEMBL30542248 0.81 HPGD (0.60) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL331059 0.81 ALDH1A1 (0.59) RAPGEF4MAPK13MAPK12MAPK11MAPK14
SCHEMBL4826082 0.81 HPGD (0.60) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL26510737 0.78 RAPGEF4 (0.73) RAPGEF4MEN1KMT2ARAB9ANPC1
SCHEMBL9218756 0.78 RAPGEF4 (0.53) RAPGEF4MAPK13MAPK12MAPK11MAPK14
SCHEMBL14062099 0.78 HPGD (0.56) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL29267932 0.78 ALDH1A1 (0.69) MAPK13MAPK12MAPK11MAPK14HPGD
Methyl Alcohol SCHEMBL9305637 0.77 MAPK13 (0.51) MAPK13MAPK12MAPK11MAPK14HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3613504-A1 PI-ALLYLPALLADIUM AND PI-ALLYLNICKEL COMPLEXES FOR USE AS CATALYSTS IN CARBON-CARBON AND CARBON-NITROGEN COUPLING REACTIONS Johnson Matthey Public Limited Company (GB) 2020-02-26 EP disclosed
EP-2585216-B1 PI-ALLYLPALLADIUM AND PI-ALLYLNICKEL COMPLEXES FOR USE AS CATALYSTS IN CARBON-CARBON AND CARBON-NITROGEN COUPLING REACTIONS JOHNSON MATTHEY PLC (GB) 2019-11-20 EP disclosed
US-20190016742-A1 Complexes JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2019-01-17 US disclosed
US-10167305-B2 Allyl complexes for use in coupling reactions JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2019-01-01 US disclosed
EP-0672038-B1 HERBICIDES ZENECA LTD (GB) 2000-01-19 EP disclosed
US-5856273-A CONTROLLING WEEDS ZENECA LIMITED (GB) 1999-01-05 US disclosed
EP-0672038-A1 HERBICIDES ZENECA LIMITED (GB) 1995-09-20 EP disclosed
WO-1994013652-A1 HERBICIDES ZENECA LIMITED (GB) 1994-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10167305-B2 Allyl complexes for use in coupling reactions AP3M1, AP1M1, C9 RAPGEF4 2684/4885MAPK13 3471/4885MAPK12 3633/4885
US-20190016742-A1 Complexes C5, C1S, C9 RAPGEF4 2359/4885MAPK13 4403/4885MAPK12 4212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.